Abstract
Aspirin is commonly used to treat migraine attacks, although sumatriptan, a much more expensive treatment, is also effective. We compared a combination of lysine acetylsalicylate (equivalent to 900 mg aspirin) and 10 mg metoclopramide (LAS+MTC) with oral sumatriptan (100 mg) and placebo in 421 patients with migraine. LAS+MTC was as effective as sumatriptan with a decrease of headache from severe or moderate to mild or none of 57% and 53%, respectively, for the first migraine attack treated. Both treatments were better than placebo (success rate 24%, p < 0.0001). LAS+MTC was significantly more effective in the treatment of nausea than sumatriptan (p < 0.0001) and was better tolerated (adverse events in 18% and 28%, respectively, p < 0.05). LAS+MTC is as effective as sumatriptan in the treatment of migraine attacks. It is also much cheaper.
Publication types
-
Clinical Trial
-
Comparative Study
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Administration, Oral
-
Adolescent
-
Adult
-
Analgesics / economics
-
Analgesics / therapeutic use*
-
Aspirin / analogs & derivatives*
-
Aspirin / economics
-
Aspirin / therapeutic use
-
Dopamine Antagonists / economics
-
Dopamine Antagonists / therapeutic use*
-
Double-Blind Method
-
Drug Costs
-
Drug Therapy, Combination
-
Female
-
Humans
-
Lysine / analogs & derivatives*
-
Lysine / economics
-
Lysine / therapeutic use
-
Male
-
Metoclopramide / economics
-
Metoclopramide / therapeutic use*
-
Middle Aged
-
Migraine Disorders / drug therapy*
-
Serotonin Receptor Agonists / adverse effects
-
Serotonin Receptor Agonists / economics
-
Serotonin Receptor Agonists / therapeutic use*
-
Sumatriptan / adverse effects
-
Sumatriptan / economics
-
Sumatriptan / therapeutic use*
Substances
-
Analgesics
-
Dopamine Antagonists
-
Serotonin Receptor Agonists
-
Sumatriptan
-
Lysine
-
Metoclopramide
-
Aspirin
-
acetylsalicylic acid lysinate